Barclays analyst Luke Sergott downgraded Waters to Equal Weight from Overweight with a $275 price target. With the stock running into the price target, the analyst struggles to see more multiple expansion given the sentiment on the group. As such, the firm is moving to the sidelines and waiting for more clarity on the downcycle duration amid the dynamic in China and biopharma macro environment.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on WAT:
- Waters downgraded to In Line from Outperform at Evercore ISI
- Agilent downgraded to In Line from Outperform at Evercore ISI
- Citi lowers Waters target, initiates ‘negative catalyst watch’
- Waters price target lowered to $290 from $325 at Barclays
- Waters, Princeton University announce multi-year research collaboration